$FOR
Forestar Group Inc. Stock $for

$for Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-K Financial Statement

#000140658721000093 Filed on November 18, 2021

Income Statement

Concept	2021 Q3	2021	2020 Q3
Revenue	$418.7M	$1.326B	$347.6M
YoY Change	20.45%	42.28%	47.1%
Cost Of Revenue	$342.8M	$1.097B	$303.4M
YoY Change	12.99%	34.77%	42.37%
Gross Profit	$75.90M	$229.2M	$44.10M
YoY Change	72.11%	94.07%	90.09%
Gross Profit Margin	18.13%	17.29%	12.69%
Selling, General & Admin	$19.70M	$68.40M	$12.90M
YoY Change	52.71%	49.67%	41.76%
% of Gross Profit	25.96%	29.84%	29.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$600.0K	$2.700M	$700.0K
YoY Change	-14.29%	-44.9%	-63.16%
% of Gross Profit	0.79%	1.18%	1.59%
Operating Expenses	$19.70M	$68.40M	$12.90M
YoY Change	52.71%	49.67%	41.76%
Operating Profit	$56.20M	$160.8M	$31.20M
YoY Change	80.13%	122.1%	121.28%
Interest Expense	$0.00	$1.400M	$800.0K
YoY Change	-100.0%		-42.86%
% of Operating Profit	0.0%	0.87%	2.56%
Other Income/Expense, Net
YoY Change
Pretax Income	$58.80M	$146.6M	$32.00M
YoY Change	83.75%	87.71%	100.0%
Income Tax	$14.70M	$36.10M	$7.500M
% Of Pretax Income	25.0%	24.62%	23.44%
Net Earnings	$44.00M	$110.2M	$24.20M
YoY Change	81.82%	81.25%	90.55%
Net Earnings / Revenue	10.51%	8.31%	6.96%
Basic Earnings Per Share	$0.89	$2.25	$0.50
Diluted Earnings Per Share	$0.89	$2.25	$0.50
COMMON SHARES
Basic Shares Outstanding	49.53M shares	48.90M shares	48.06M shares
Diluted Shares Outstanding		48.98M shares

Balance Sheet

Concept	2021 Q3	2021	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$153.6M	$153.6M	$394.3M
YoY Change	-61.04%	-61.04%	3.0%
Cash & Equivalents	$153.6M	$153.6M	$394.3M
Short-Term Investments
Other Short-Term Assets	$15.40M	$15.40M	$4.900M
YoY Change	214.29%	214.29%	44.12%
Inventory
Prepaid Expenses
Receivables	$400.0K	$400.0K	$400.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$169.4M	$169.4M	$399.6M
YoY Change	-57.61%	-57.61%	3.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.900M	$1.915B	$1.100M
YoY Change	163.64%	45.69%	-54.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$900.0K	$900.0K	$3.600M
YoY Change	-75.0%	-75.0%	-50.68%
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$1.932B	$1.932B	$1.340B
YoY Change	44.17%	44.17%	25.45%
TOTAL ASSETS
Total Short-Term Assets	$169.4M	$169.4M	$399.6M
Total Long-Term Assets	$1.932B	$1.932B	$1.340B
Total Assets	$2.102B	$2.102B	$1.740B
YoY Change	20.79%	20.79%	19.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$47.40M	$47.40M	$29.20M
YoY Change	62.33%	62.33%	73.81%
Accrued Expenses	$140.5M	$140.5M	$73.30M
YoY Change	91.68%	91.68%	12.77%
Deferred Revenue	$5.800M		$200.0K
YoY Change	2800.0%		-92.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$343.0M	$343.0M	$201.3M
YoY Change	70.39%	70.39%	17.24%
LONG-TERM LIABILITIES
Long-Term Debt	$704.5M	$704.5M	$641.1M
YoY Change	9.89%	9.89%	39.22%
Other Long-Term Liabilities	$13.90M	$13.90M	$20.00M
YoY Change	-30.5%	-30.5%	277.36%
Total Long-Term Liabilities	$718.4M	$718.4M	$661.1M
YoY Change	8.67%	8.67%	41.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$343.0M	$343.0M	$201.3M
Total Long-Term Liabilities	$718.4M	$718.4M	$661.1M
Total Liabilities	$1.086B	$1.087B	$868.1M
YoY Change	25.08%	25.06%	34.21%
SHAREHOLDERS EQUITY
Retained Earnings	$329.1M		$218.9M
YoY Change	50.34%		38.46%
Common Stock	$685.8M		$652.0M
YoY Change	5.18%		0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.015B	$1.015B	$870.9M
YoY Change
Total Liabilities & Shareholders Equity	$2.102B	$2.102B	$1.740B
YoY Change	20.79%	20.79%	19.52%

Cashflow Statement

Concept	2021 Q3	2021	2020 Q3
OPERATING ACTIVITIES
Net Income	$44.00M	$110.2M	$24.20M
YoY Change	81.82%	81.25%	90.55%
Depreciation, Depletion And Amortization	$600.0K	$2.700M	$700.0K
YoY Change	-14.29%	-44.9%	-63.16%
Cash From Operating Activities	$37.50M	-$303.1M	$37.30M
YoY Change	0.54%	79.99%	-36.67%
INVESTING ACTIVITIES
Capital Expenditures	-$1.100M	$1.600M	$0.00
YoY Change		166.67%
Acquisitions
YoY Change
Other Investing Activities	$400.0K	$2.600M	$1.900M
YoY Change	-78.95%	-53.57%
Cash From Investing Activities	-$700.0K	$1.000M	$1.900M
YoY Change	-136.84%	-80.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$33.40M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	800.0K	$61.40M	-500.0K
YoY Change	-260.0%	-64.89%	-100.5%
NET CHANGE
Cash From Operating Activities	37.50M	-$303.1M	37.30M
Cash From Investing Activities	-700.0K	$1.000M	1.900M
Cash From Financing Activities	800.0K	$61.40M	-500.0K
Net Change In Cash	37.60M	-$240.7M	38.70M
YoY Change	-2.84%	-2193.04%	-75.75%
FREE CASH FLOW
Cash From Operating Activities	$37.50M	-$303.1M	$37.30M
Capital Expenditures	-$1.100M	$1.600M	$0.00
Free Cash Flow	$38.60M	-$304.7M	$37.30M
YoY Change	3.49%	80.3%	-36.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001406587
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2020Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-33662
CY2021	dei	Entity Registrant Name EntityRegistrantName	Forestar Group Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1336998
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	2221 E. Lamar Blvd.
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 790
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Arlington
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	76006
CY2021	dei	City Area Code CityAreaCode	817
CY2021	dei	Local Phone Number LocalPhoneNumber	769-1860
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $1.00 per share
CY2021	dei	Trading Symbol TradingSymbol	FOR
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Public Float EntityPublicFloat	410000000	USD
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49588389	shares
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153600000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	394300000	USD
CY2021Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1905200000	USD
CY2020Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1309700000	USD
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	900000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	3600000	USD
CY2021Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	0	USD
CY2020Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	6300000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2900000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1100000	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	39100000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	24900000	USD
CY2021Q3	us-gaap	Assets Assets	2101700000	USD
CY2020Q3	us-gaap	Assets Assets	1739900000	USD
CY2021Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	47400000	USD
CY2020Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	29200000	USD
CY2021Q3	for	Accrued Development Costs AccruedDevelopmentCosts	104500000	USD
CY2020Q3	for	Accrued Development Costs AccruedDevelopmentCosts	44400000	USD
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	148300000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	98300000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	24400000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	5700000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	56700000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	49400000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	704500000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	641100000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	1085800000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	868100000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.00
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49580389	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48061921	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	49600000	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	48100000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	636200000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	603900000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	329100000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	218900000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1014900000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	870900000	USD
CY2021Q3	us-gaap	Minority Interest MinorityInterest	1000000.0	USD
CY2020Q3	us-gaap	Minority Interest MinorityInterest	900000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1015900000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	871800000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2101700000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1739900000	USD
CY2021	us-gaap	Revenues Revenues	1325800000	USD
CY2020	us-gaap	Revenues Revenues	931800000	USD
CY2019	us-gaap	Revenues Revenues	428300000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1096600000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	813700000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	362700000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	68400000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	45700000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28900000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	200000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	700000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2500000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	100000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3000000.0	USD
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	1200000	USD
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	4900000	USD
CY2019	us-gaap	Interest And Other Income InterestAndOtherIncome	5500000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18100000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	146600000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78100000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45700000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36100000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16400000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9400000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	110500000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	36300000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	900000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3300000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	110200000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	33000000.0	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.25
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48900000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48000000.0	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42000000.0	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49000000.0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48100000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42000000.0	shares
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	674500000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	36300000	USD
CY2019	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6037500	shares
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100700000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1300000	USD
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3900000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	808900000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	300000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2000000.0	USD
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	600000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	871800000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	110500000	USD
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1448520	shares
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	33400000	USD
CY2021	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-1800000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	600000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2600000	USD
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	100000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1015900000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	110500000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	61700000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	36300000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2700000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4900000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6700000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-19200000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-23100000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-9500000	USD
CY2020	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	200000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	700000	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	500000	USD
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	0	USD
CY2019	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	4900000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2600000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2000000.0	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1300000	USD
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	3000000.0	USD
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	900000	USD
CY2019	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1300000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18100000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2500000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	100000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3000000.0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-100000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-100000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-100000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	585900000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	281700000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	531700000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	14800000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3400000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-300000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	28000000.0	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15000000.0	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	24400000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	60100000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	9000000.0	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	17500000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	49700000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3900000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	40500000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6300000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3100000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1200000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-303100000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-168400000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-391200000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1600000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	600000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	900000	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2600000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	4300000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	100000	USD
CY2021	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
CY2020	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	1300000	USD
CY2019	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1000000.0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5000000.0	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-800000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	33400000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	100700000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	458000000.0	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	300000000.0	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	435000000.0	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	422000000.0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	118900000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	85000000.0	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4900000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5300000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6900000	USD
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-2400000	USD
CY2020	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2019	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	100000	USD
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	600000	USD
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	3900000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	600000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	300000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	100000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61400000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	174900000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	439800000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-240700000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11500000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47800000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	394300000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382800000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	335000000.0	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153600000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	394300000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382800000	USD
CY2021	us-gaap	Notes Issued1 NotesIssued1	12500000	USD
CY2020	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2019	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4300000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-3100000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1700000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Presentation and Reclassifications</span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain items have been reclassified in the prior year financial statements to conform to the presentation and classifications used in the current year. Accrued development costs have been reclassified from accrued expenses and other liabilities to accrued development costs in the prior year consolidated balance sheet. The Company has reclassified the change in accrued development costs from the change in accounts payable and other liabilities to the change in accrued development costs in the prior year statement of cash flows. These reclassifications had no net effect on the Company's consolidated operating results, financial position or cash flows.</span></div>
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2021Q3	us-gaap	Deposits Assets DepositsAssets	10400000	USD
CY2020Q3	us-gaap	Deposits Assets DepositsAssets	5500000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3800000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2300000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	900000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1200000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2900000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1100000	USD
CY2021	us-gaap	Depreciation Depreciation	400000	USD
CY2019	us-gaap	Depreciation Depreciation	300000	USD
CY2020	us-gaap	Depreciation Depreciation	300000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P4Y6M
CY2021Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1905200000	USD
CY2020Q3	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	1309700000	USD
CY2021	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	779700000	USD
CY2021	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	850700000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	800000	USD
CY2021	for	Due Diligence Write Offs DueDiligenceWriteOffs	3000000	USD
CY2020	for	Due Diligence Write Offs DueDiligenceWriteOffs	900000	USD
CY2019	for	Due Diligence Write Offs DueDiligenceWriteOffs	200000	USD
CY2021	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	32700000	USD
CY2020	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	51500000	USD
CY2019	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	76600000	USD
CY2021	us-gaap	Revenues Revenues	1325800000	USD
CY2020	us-gaap	Revenues Revenues	931800000	USD
CY2019	us-gaap	Revenues Revenues	428300000	USD
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	48700000	USD
CY2019Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	23700000	USD
CY2018Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	3200000	USD
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	41500000	USD
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	43300000	USD
CY2019	us-gaap	Interest Costs Incurred InterestCostsIncurred	25300000	USD
CY2021	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	36500000	USD
CY2020	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	18300000	USD
CY2019	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	4800000	USD
CY2021Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	53700000	USD
CY2020Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	48700000	USD
CY2019Q3	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	23700000	USD
CY2021Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	400000	USD
CY2020Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	400000	USD
CY2021Q3	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	700000	USD
CY2020Q3	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	4800000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6900000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3600000	USD
CY2021Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	15400000	USD
CY2020Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	4900000	USD
CY2021Q3	us-gaap	Deposits Assets DepositsAssets	10400000	USD
CY2020Q3	us-gaap	Deposits Assets DepositsAssets	5500000	USD
CY2021Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	5300000	USD
CY2020Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	5700000	USD
CY2021Q3	us-gaap	Other Assets OtherAssets	39100000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	24900000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	7900000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	6200000	USD
CY2021Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	3400000	USD
CY2020Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	3800000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7300000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3800000	USD
CY2021Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	8500000	USD
CY2020Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	14000000.0	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5800000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000	USD
CY2021Q3	us-gaap	Deferred Revenue DeferredRevenue	6800000	USD
CY2020Q3	us-gaap	Deferred Revenue DeferredRevenue	9300000	USD
CY2021Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	6800000	USD
CY2020Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	500000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	8900000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	10200000	USD
CY2021Q3	us-gaap	Other Liabilities OtherLiabilities	1300000	USD
CY2020Q3	us-gaap	Other Liabilities OtherLiabilities	1400000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	56700000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	49400000	USD
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2020Q3	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	704500000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	641100000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	410000000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	600000000	USD
CY2021Q3	for	Letterof Credit Maximum Borrowing Capacity LetterofCreditMaximumBorrowingCapacity	100000000	USD
CY2021Q3	for	Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment	0.50
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	58000000	USD
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	58000000	USD
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2021Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	60300000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	349700000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-18100000	USD
CY2020Q2	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	USD
CY2021Q3	for	Debt Repurchase Program Authorized Amount DebtRepurchaseProgramAuthorizedAmount	30000000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	110200000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	60800000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	33000000.0	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48901987	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48037018	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41974429	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	73674	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	57093	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	30712	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48975661	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48094111	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42005141	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.25
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.26
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.79
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.26
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	14300000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-7600000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-300000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2600000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	900000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	300000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16900000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-6700000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	15800000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	21200000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	9100000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3400000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1900000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	300000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19200000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23100000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9400000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36100000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16400000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9400000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.033
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.020
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.003
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.014
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	-0.010
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Percent EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1200000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.210
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.206
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2300000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	14200000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	10500000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	1900000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	1500000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1400000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1700000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	200000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	200000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17700000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13900000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1500000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	16500000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12400000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	40900000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	18100000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	40900000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	18100000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	24400000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5700000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1200000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1500000	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	USD
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1600000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-1600000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	USD
CY2018Q3	for	Equity Securities Registered Value EquitySecuritiesRegisteredValue	500000000	USD
CY2018Q3	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	100000000	USD
CY2021Q3	for	At The Market Equity Offering Program Common Stock Issued AtTheMarketEquityOfferingProgramCommonStockIssued	1400000	shares
CY2021	for	At The Market Equity Offering Program Net Proceeds AtTheMarketEquityOfferingProgramNetProceeds	33400000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1000000	USD
CY2021Q3	for	Common Stock Availablefor Issuance Value Remaining CommonStockAvailableforIssuanceValueRemaining	359900000	USD
CY2021Q3	for	At The Market Equity Offering Program Common Stock Available For Issuance AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance	65600000	USD
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	285863	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	17.47
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	200960	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.68
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	86500	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.09
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	234000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.13
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	181325	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.11
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	149400	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.24
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	92159	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.08
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	79432	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	19.58
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	23740	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	18.03
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	40550	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.66
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	16990	shares
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1900000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	19.10
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	11200	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	18.39
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	387154	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.70
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	285863	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	17.47
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	200960	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.68
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1600000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	5000000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2021Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	60300000	USD
CY2021Q3	us-gaap	Special Assessment Bond SpecialAssessmentBond	479300000	USD
CY2021Q3	us-gaap	Deposits Assets DepositsAssets	10400000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1700000	USD
CY2021Q3	us-gaap	Purchase Obligation PurchaseObligation	597500000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1900000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1500000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1000000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1100000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	USD
CY2021Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	64400	Lot
CY2020Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	42400	Lot
CY2021	for	Numberof Lots Sold NumberofLotsSold	15915	Lot
CY2020	for	Numberof Lots Sold NumberofLotsSold	10373	Lot
CY2019	for	Numberof Lots Sold NumberofLotsSold	4132	Lot
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	6700000	USD
CY2020Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	8400000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	153600000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	394300000	USD
CY2020Q4	us-gaap	Revenues Revenues	307100000	USD
CY2021Q1	us-gaap	Revenues Revenues	287100000	USD
CY2021Q2	us-gaap	Revenues Revenues	312900000	USD
CY2021Q3	us-gaap	Revenues Revenues	418700000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29200000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	37600000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	21100000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	58800000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7100000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9200000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5200000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14700000	USD
CY2020Q4	us-gaap	Profit Loss ProfitLoss	22100000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	28400000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	15900000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	44100000	USD
CY2020Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	100000	USD
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	100000	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	100000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	22000000.0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	28400000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	15800000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	44000000.0	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5400000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3300000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.89
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.59
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2019Q4	us-gaap	Revenues Revenues	247200000	USD
CY2020Q1	us-gaap	Revenues Revenues	159100000	USD
CY2020Q2	us-gaap	Revenues Revenues	177900000	USD
CY2020Q3	us-gaap	Revenues Revenues	347600000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22200000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13700000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10300000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	32000000.0	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7500000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2019Q4	us-gaap	Profit Loss ProfitLoss	16800000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	10400000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	10100000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	24500000	USD
CY2019Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	800000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	16900000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	9600000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	10100000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	24200000	USD
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50

Files In Submission

Name	View Source	Status
0001406587-21-000093-index-headers.html	Edgar Link	pending
0001406587-21-000093-index.html	Edgar Link	pending
0001406587-21-000093.txt	Edgar Link	pending
0001406587-21-000093-xbrl.zip	Edgar Link	pending
a9302021ex211subsidiarylis.htm	Edgar Link	pending
a9302021ex231auditconsent.htm	Edgar Link	pending
a9302021exhibit311.htm	Edgar Link	pending
a9302021exhibit312.htm	Edgar Link	pending
a9302021exhibit321.htm	Edgar Link	pending
a9302021exhibit322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
for-20210930.htm	Edgar Link	pending
for-20210930.xsd	Edgar Link	pending
for-20210930_cal.xml	Edgar Link	unprocessable
for-20210930_def.xml	Edgar Link	unprocessable
for-20210930_g1.jpg	Edgar Link	pending
for-20210930_htm.xml	Edgar Link	completed
for-20210930_lab.xml	Edgar Link	unprocessable
for-20210930_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOR
Forestar Group Inc. Stock $for

2021 Q3 Form 10-K Financial Statement

#000140658721000093 Filed on November 18, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR Forestar Group Inc. Stock $for

2021 Q3 Form 10-K Financial Statement

#000140658721000093 Filed on November 18, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOR
Forestar Group Inc. Stock $for